[go: up one dir, main page]

HK1188129A - 包含决奈达隆的药物组合物和剂型，及其制备方法 - Google Patents

包含决奈达隆的药物组合物和剂型，及其制备方法 Download PDF

Info

Publication number
HK1188129A
HK1188129A HK14101204.4A HK14101204A HK1188129A HK 1188129 A HK1188129 A HK 1188129A HK 14101204 A HK14101204 A HK 14101204A HK 1188129 A HK1188129 A HK 1188129A
Authority
HK
Hong Kong
Prior art keywords
composition according
advantageously
benzoyl
composition
butylaminopropoxy
Prior art date
Application number
HK14101204.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1188129B (zh
Inventor
Bernard Abramovici
Stéphane Beilles
Jean-Claude Gautier
Sandra Chambonnet
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HK1188129A publication Critical patent/HK1188129A/zh
Publication of HK1188129B publication Critical patent/HK1188129B/zh

Links

HK14101204.4A 2010-11-10 2011-11-10 包含决奈达隆的药物组合物和剂型，及其制备方法 HK1188129B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1059306 2010-11-10

Publications (2)

Publication Number Publication Date
HK1188129A true HK1188129A (zh) 2014-04-25
HK1188129B HK1188129B (zh) 2019-02-01

Family

ID=

Similar Documents

Publication Publication Date Title
JP7627302B2 (ja) パルボシクリブの固形剤形
CN102427803B (zh) 亲水性药物之自微乳化医药组合物及其制备
JP5992937B2 (ja) インドリノン誘導体の即時放出のための医薬投薬形態
KR101716878B1 (ko) 글리세롤 지방산에스테르유도체 또는 프로필렌글리콜 지방산에스테르유도체를 함유한 두타스테리드와 타다라필의 복합 캡슐제제 조성물 및 이의 제조방법
WO2012122274A1 (en) Self-emulsifying formulations and methods of use thereof
EA008103B1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор сох-2), растворитель, жирную кислоту и органический амин
US20150196528A1 (en) Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
WO2015022349A1 (en) Dosage form comprising enzalutamide
BRPI0609497A2 (pt) formulações aprimoradas de fenofibrato
US20140073670A1 (en) Pharmaceutical composition comprising fexofenadine
WO2004062692A1 (en) Formulation of poorly water-soluble active substances
HK1188129A (zh) 包含决奈达隆的药物组合物和剂型，及其制备方法
US20200368221A1 (en) Solid particle, preparation method therefor, and pharmaceutical composition containing solid particle
US20100221326A1 (en) Pharmaceutical compositions for oral use for treating patients affected by obesity
HK1188129B (zh) 包含决奈达隆的药物组合物和剂型，及其制备方法
CN107693516A (zh) 一种地拉罗司药物组合物及其药物制剂、制备方法和用途
AU2018225546A1 (en) Solid oral formulations of amphotericin B
TW201311239A (zh) 包含非索非那定（ｆｅｘｏｆｅｎａｄｉｎｅ）之醫藥組成物
JP2025530029A (ja) エダラボンの経口製剤およびその改良された製造方法
AU2012260992A1 (en) Pharmaceutical composition comprising fexofenadine
OA19944A (en) Pharmaceutical composition comprising fexofenadine.